Health Bulletin 24/September/2022

Here are the top health news for the day:

Submit complete CT Report: CDSCO tells Glenmark on antidiabetic FDC drug

In response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate 0.5/0.5mg plus Metformin HCL 500/1000mg ER tablets, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has recommended Glenmark to submit the complete clinical trial report.

This came after the drug maker Glenmark presented their proposal for manufacturing and marketing of Lobeglitazone Sulphate 0.5/0.5mg plus Metformin HCL 500/1000mg ER tablets along with safety efficacy and safety data.

For more details, check out the link given below:

Submit Complete CT Report: CDSCO Tells Glenmark On Antidiabetic FDC Drug

Failed tubectomy not medical negligence: Supreme Court Sets aside NCDRC order awarding compensation

Observing an error in the judgment of the National Consumer Disputes Redressal Commission (NCDRC), the Supreme Court recently set aside the order of the top consumer court which had awarded compensation to a woman after she gave birth to a child despite undergoing a Tubectomy procedure.

However, the Apex Court clarified that if any amount has already been paid to the concerned woman, the State shall not demand a refund.

The concerned woman had undergone the Tubectomy operation twice on 23rd September 1994 and 27th February 1998. However, both the procedures remained unsuccessful and she gave birth to a male child in 2003. Following this, the woman had filed a complaint before the District Consumer Forum alleging medical negligence on account of failed tubectomy surgery.

For more details, check out the link given below:

Failed Tubectomy Not Medical Negligence: Supreme Court Sets Aside NCDRC Order Awarding Compensation

Dr Rajiv Bahl is the new Director-General of ICMR

Renowned WHO official Dr Rajiv Bahl has recently been appointed as the Director General of the apex research regulator, Indian Council of Medical Research (ICMR) cum- Secretary of the Department of Health Research (DHR). He has been assigned the post for three years.

Dr Bahl has been serving as head of research in the maternal, newborn child, and adolescent Health-cum-Newborn unit of the World Health Organization (WHO). The order of his appointment was issued on 23rd September 2022 by the Secretariat of the Appointments Committee of the Cabinet Ministry of Personnel Public Grievances and Pensions, Department of Personnel and Training, Government of India.

For more details, check out the link given below:

Maternal, Newborn Child Specialist Dr Rajiv Bahl Takes Charge As Director General ICMR